Febuxostat was studied in healthy subjects in doses up to 300 mg daily for seven days without evidence of dose-limiting toxicities. No overdose of Febuxostat was reported in clinical studies. Patients should be managed by symptomatic and supportive care should there be an overdose.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign Out
